Skip to main content
Log in

Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Furlanetto TW, Faulhaber GA (2011) Hypomagnesaemia and proton pump inhibitors: below the tip of the iceberg. Arch Intern Med 171(15):1391–1392

    Article  PubMed  Google Scholar 

  2. Shabajee N, Lamb EJ, Sturgess I, Sumathipala RW (2008) Omeprazole and refractory hypomagnesaemia. BMJ 337:a425

    Article  CAS  PubMed  Google Scholar 

  3. Pasina L, Zanotta D, Puricelli S, Djignefa DC, Bonoldi G (2015) Proton pump inhibitors and risk of hypomagnesaemia. Eur J Intern Med 26(7):e25–e26

    Article  CAS  PubMed  Google Scholar 

  4. Zipursky J, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Paterson JM, Lathia N, Juurlink DN (2014) Proton pump inhibitors and hospitalization with hypomagnesaemia: a population-based case-control study. PLoS Med 11(9)

  5. Deroux A, Khouri C, Chabre O, Bouillet L, Casez O (2014) Severe acute neurological symptoms related to proton pump inhibitors induced hypomagnesaemia responsible for profound hypoparathyroidism with hypocalcaemia. Clin Res Hepatol Gastroenterol 38(5):e103–e105

    Article  CAS  PubMed  Google Scholar 

  6. Cundy T, Mackay J (2011) Proton pump inhibitors and severe hypomagnesaemia. Curr Opin Gastroenterol 27(2):180–185

    Article  CAS  PubMed  Google Scholar 

  7. Park CH, Kim EH, Roh YH, Kim HY, Lee SK (2014) The association between the use of proton pump inhibitors and the risk of hypomagnesaemia: a systematic review and meta-analysis. PLoS One 9(11):e112558

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rosa RG, Barros AJ, de Lima AR et al (2014) Mood disorder as a manifestation of primary hypoparathyroidism: a case report. J Med Case Rep 8:326

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R (2010) A case series of proton pump inhibitor-induced hypomagnesaemia. Am J Kidney Dis 56(1):112–116

    Article  PubMed  Google Scholar 

  10. Pasina L, Zanotta D, Puricelli S, Bonoldi G (2016) Acute neurological symptoms secondary to hypomagnesaemia induced by proton pump inhibitors: a case series. Eur J Clin Pharmacol 72(5):641–643

    Article  PubMed  Google Scholar 

  11. Famularo G, Minisola G, Bravi MC, Colucci P, Gasbarrone L (2012) Tetany, hypomagnesaemia, and proton-pump inhibitors. Am J Med 125(10):e7–e8

    Article  PubMed  Google Scholar 

  12. Arulanantham N, Anderson M, Gittoes N, Ferner RE (2011) A 63-year-old man with hypomagnesaemia and seizures. Clin Med December 11:591–593

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to J.D. Baggott for editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luca Pasina.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pasina, L., Zanotta, D., Puricelli, S. et al. Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor. Eur J Clin Pharmacol 73, 511–512 (2017). https://doi.org/10.1007/s00228-016-2169-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-016-2169-z

Keywords

Navigation